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ABSTRACT 27 
This study describes results of a randomized clinical trial investigating the effect of oxytetracycline 28 
treatment dose and mode of administration on selection of antibiotic resistant coliform bacteria in 29 
fecal samples from nursery pigs. Nursery pigs (pigs of 4-7 weeks of age) were treated with 30 
oxytetracycline against Lawsonia intracellularis induced diarrhea in five pig herds. Each group was 31 
randomly allocated to one of five treatment groups: oral flock treatment with (i) high (20 mg/kg), 32 
(ii) medium (10 mg/kg) and (iii) low (5 mg/kg) dosage, (iv) oral-pen-wise (small group) treatment 33 
(10 mg/kg), and (v) individual intramuscular injection treatment (10mg/kg). All groups were 34 
treated once a day for five days. In all groups, treatment caused a rise in numbers and proportion 35 
of tetracycline resistant coliform bacteria right after treatment, followed by a significant drop by 36 
the time where pigs left the nursery unit. Counts and proportion of tetracycline-resistant coliforms 37 
did not vary significantly between treatment groups, except immediately after treatment, where 38 
the highest treatment dose resulted in the highest number of resistant coliforms. A control group 39 
treated with tiamuline did not show significant changes in number or proportion of tetracycline 40 
resistant coliforms. Selection for tetracycline-resistant coliforms was significantly correlated to 41 
selection for ampicillin- and sulfonamide-resistant, but not to cefotaxime-resistant strains. In 42 
conclusion, difference in dose of oxytetracycline and the way the drug was applied did not cause 43 
significantly different selection of tetracycline resistant coliform bacteria, under the conditions 44 
tested.  45 
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IMPORTANCE 47 
Antimicrobial resistance is a global treat to human health. Treatment of livestock with 48 
antimicrobials has a direct impact on this problem, and there is a need to improve the ways that 49 
we use antimicrobial in livestock production. We hypothesized that antibiotic resistance 50 
development following treatment of diarrhea in nursery pigs could be reduced by either lowering 51 
the dose of oxytetracycline or by replacing the commonly used practice of flock treatment with 52 
individual or small group treatments, since this would reduce the number of pigs treated. 53 
However, the study showed no significant difference between treatment-groups with respect to 54 
the number or proportion of tetracycline resistant coliforms selected. The most important 55 
conclusion is that under the practical field conditions, there will be no added value in terms of 56 
lowering resistance development by exchanging flock treatment with individual or small group 57 
treatment of nursery pigs. The reason for lack of effect of single animal treatment is probably that 58 
such animals share the environment with treated animals and take up resistant bacteria from the 59 
environment.    60 
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INTRODUCTION 61 
Antibiotic resistant bacteria are a recognized threat to public health. They cause increased 62 
mortality of infectious diseases (1), higher cost of treatments due to prolonged recovery time and 63 
use of more expensive antibiotics, and they increase the need for, and thus the cost of, biosecurity 64 
in hospitals (2). The same is true in veterinary medicine, where resistant bacteria increase the cost 65 
of treatment and may lead to animal welfare problems due to unsuccessful treatments (3, 4). For 66 
these reasons, it is important to reduce selection of antibiotic resistant bacteria as far as possible. 67 
 68 
Antibiotic resistance in the animal sector can reach humans through the food chain, the 69 
environment, and by direct and indirect contact to animals and animal products (5, 6). While 70 
antibiotic resistant pathogenic bacteria are the immediate threat, antibiotic resistance in 71 
commensal bacteria of food animals is considered a reservoir of antibiotic resistance genes that 72 
may aggravate the problem (7). For example, surveillance results show 36 % tetracycline 73 
resistance in commensal E. coli from pigs in Denmark (8).  Thus, minimizing resistance in the 74 
commensal flora of food animals may be important in order to reduce the risk to human health 75 
from use of antibiotics in the livestock industry.  76 
 77 
Enteric disease is very common in industrial pig production, especially in the nursery period (9). As 78 
a consequence, the highest single indication for use of antibiotics in the Danish livestock industry 79 
is treatment of diarrhoea in pigs in this period, and 42 % of total antibiotic use for pigs in Denmark 80 
is for this indication, with tetracycline as the most used drug class (8). In order to reduce the total 81 
amount of antibiotics used in the pig industry, it is important to find more intelligent ways to treat 82 
enteric diseases in the nursery period.  83 
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 84 
Treatment of nursery pigs against diarrhea is often carried out using oral flock-treatment, where a 85 
full section of pigs is treated with antibiotic in the feed or water, when disease is seen in a pre-86 
fixed proportion of the population. The justification for this approach is that apparently healthy 87 
animals in close proximity to diseased individuals are likely to be sub-clinically infected and will 88 
progress to develop clinical disease(10, 11). This batch treatment regime exposes the commensal 89 
intestinal flora of all pigs to a selective pressure, which is presumed to increase the total amount 90 
of resistant bacteria in farms significantly, when compared to treatment of individual pigs (12, 13). 91 
However, to the authors’ knowledge, this has not been investigated under field conditions.  92 
 93 
Apart from the treatment regime (flock versus individual treatment), selection of antibiotic 94 
resistant bacteria are influenced by factors such as treatment-dose(14, 15), number of animals 95 
housed together(16), and other management factors (17-21). Among these factors, mathematical 96 
modeling suggests that dose may play a particularly important role for selection of resistant 97 
coliform bacteria following tetracycline treatment (22). Such modeling predicts that consumption 98 
of high doses of antibiotics is positively correlated to a subsequent high proportion of resistant 99 
fecal coliforms and to a longer time required for the proportion of resistant bacteria to non-100 
resistant bacteria to return to pre-treatment equilibrium.  101 
 102 
The aim of the present study was to determine the effect of five different oxytetracycline (OTC) 103 
treatment regimens with varying doses and varying modes of treatment on occurrence of 104 
antibiotic resistant coliform bacteria in nursery pigs in a randomized clinical field trial. 105 
 106 
 o
n
 M
ay 17, 2017 by TECH KNO
W
LEDG
E CTR O
F DENM
ARK
http://aem
.asm
.org/
D
ow
nloaded from
 
 7
MATERIAL AND METHODS 107 
Clinical field trial  108 
The set-up of the randomized clinical field trial has previously been described in two studies 109 
measuring the efficacy of varying OTC treatment doses and treatment regimes (administration 110 
routes) for Lawsonia intracellularis diarrhea (11, 23), and the reader is referred to those two 111 
studies for a comprehensive description and for calculation of sample size. In brief, five herds with 112 
history of L. intracellularis induced diarrhea were pre-selected. Each herd had between 2300 and 113 
3600 pen places, and an all-in all-out batch production in sectioned compartments. The flooring 114 
consisted of 1/3 solid floor and 2/3 slatted floor. In each herd 15 batches were included in the 115 
study after being weaned. At clinical signs of diarrhoea they were treated as described below and 116 
followed until at least the end of the seven-week nursery period. Where possible, pigs were also 117 
re-sampled in the week prior to slaughter. A batch was defined as a group of nursery pigs weaned 118 
at the same time and housed in a number of pens within one stable. In each batch 15 animals, 119 
randomly distributed over pens, were selected as trial pigs. The allocated treatment regimen, 120 
however, was applied to all pigs in the section as previously described (23). All trial pigs were ear 121 
tagged with a unique ID.  122 
 123 
When a new batch was weaned, it was monitored once a week for outbreak of diarrhea. When an 124 
outbreak was detected, defined as at least 25 % pigs showing clinical signs of enteritis (watery 125 
feces, scouring of the back and/or a poor body score), pigs were subjected to one of five 126 
treatment regimens: oral flock-treatment in water with a standard dose of 10 mg/kg OTC 127 
(Terramycin®Vet. 20 %, Orion Pharma) for five days (ND, normal dose), oral flock-treatment in 128 
water with 20 mg/kg OTC for five days (HD, high dose); oral flock-treatment in water with 5 mg/kg 129 
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OTC for five days (LD, low dose), oral pen-wise (small group) treatment in water with a standard 130 
dose of 10 mg/kg OTC for five days (PW) or individual intra muscular treatment (IM) of pigs with 131 
diarrhea with a standard dose of 10 mg/kg OTC for five days. Pen-wise treatment was initiated 132 
when more than 25% of pigs in a pen had clinical signs of enteritis, while intramuscular treatment 133 
was initiated in animals showing clinical signs of enteritis. Flock treatment was administered 134 
through the common water supply, whereas pen-wise treatment was administered in water in 135 
troughs to pigs also having access to medicine-free water through the common water supply. Each 136 
treatment was repeated three times in each herd, and the order of the treatments was chosen at 137 
random. The number of pigs included from each farm in the different groups can be seen in Table 138 
1. Outbreaks of diarrhea, and thus initiation of treatment, occurred from 2 to 6 weeks after 139 
weaning. 140 
 141 
In order to be able to estimate selection of tetracycline-resistant coliform bacteria in pigs not 142 
exposed to tetracycline treatment, 25 pigs in one additional batch in herd A, suffering from an 143 
outbreak of diarrhea, were treated by oral flock-treatment with a standard dose (8 mg/kg) of 144 
tiamuline (Denagard®Vet, Novartis, Copenhagen, Denmark) for three days.  145 
 146 
All pigs in the trial received 2500 ppm zinc-oxide supplement in the feed the first 14 days after 147 
weaning. Farmers were asked to keep record on all antibiotic treatments carried out in the herd 148 
before and during the field trial. This allowed controlling for confounding due to additional 149 
antibiotics treatments.  A total of 889 pigs received antibiotic treatment before T1, and 402 pigs 150 
received treatment during the trial period between T2 and T3 (Supplementary material, Table S1). 151 
The treatments were farm specific: At one farm, pigs did very rarely received additional 152 
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 9
treatments, neither before nor after the study treatment protocol. On three of the farms, the 153 
farmer regularly treated pigs with colistin shortly after entering the nursery unit, i.e. shortly before 154 
the trial period. On two of these three farms, other treatments than this was rare, while the 155 
remaining farmer additionally treated some pigs with doxycycline between T2 and T3.  Finally, on 156 
one farm, pigs were often treated with amoxicillin before T1, but with no other treatments 157 
between T2 and T3. Antibiotic treatments between T3 and T4 were not consistently recorded and 158 
were thus not taken into account in the analyses. When analyzing for the effect of pre- and post-159 
treatment with antibiotics there were no significant effect of the three largest additional 160 
treatment groups (colistin treatment before T1, amoxicillin treatment before T1, and doxycycline 161 
treatment after T2) on absolute number of tetracycline resistant coliform bacteria, proportion of 162 
tetracycline resistant coliforms or change in proportion of tetracycline  resistant coliforms, and we 163 
concluded that these treatments were not confounders in our study. 164 
 165 
Sampling 166 
Faecal samples were collected from all trial pigs between October 2011 and April 2013, either at 167 
defecation or per rectum. Samples were collected from all pigs at three time points: Time point 1 168 
(T1) was the first day of treatment, immediately before antibiotic administration, Time point 2 (T2) 169 
was two days after the end of the five day treatment, and Time point 3 (T3) was when pigs were 170 
moved from the nursery stables to finisher stables, either in the same herd or in other herds. 171 
When possible (n=296), a fourth sample (T4) was collected from rectum 1-7 days before slaughter. 172 
Samples were stored in 40 ml containers and shipped to the laboratory in cooled boxes.  173 
 174 
Bacterial quantification   175 
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 10
10-1 w/v suspensions were made from approximately 1 g of fecal sample in PBS, and one ml of this 176 
suspension was used for preparation of 10-fold serial dilutions from 10-2 to 10-4. Twenty μl of each 177 
dilution was plated on four MacConkey agar plates (Oxoid Ltd, Thermo Scientific, Roskilde, 178 
Denmark), containing different antibiotics (16 mg/L tetracycline, 16 mg/L ampicillin, 256 mg/L 179 
sulfamethizole, or 2 mg/L cefotaxime), and on a MacConkey agar plate without added antibiotics, 180 
using the principle of the drop plate method (24) with a 4x4 grid. Antibiotics were purchased from 181 
Sigma (Sigma-Aldrich, Copenhagen, Denmark). Antibiotic concentrations were based on EUCAST 182 
epidemiological cutoffs for E. coli, as recommended in (25).  183 
 184 
Plates were incubated overnight at 37 oC followed by enumeration of dark red colonies with a size 185 
>0.5 mm. To confirm that colonies counted were coliforms, 100 colonies were randomly picked 186 
and subjected to species identification using Matrix-assisted laser desorption-ionization time-of-187 
flight mass spectrometry (MALDI-TOF MS) (Vitek MS RUO, bioMérieux, France). All colonies were 188 
shown to belong to the species E. coli (data not shown). For each plate, a count expressed as 189 
colony-forming units (CFU) per gram were determined using a weighed arithmetic mean based on 190 
the two highest dilutions showing the separation between colonies, and finally CFU/g was Log10 191 
transformed. The detection limit for the method used was 500 colony forming units per gram of 192 
feces, corresponding to Log10 = 2.70. 193 
 194 
In order to validate that this method distinguished between tetracycline resistant and susceptible 195 
isolates, at representative collection of commensal E. coli from Danish pigs, previously used to 196 
model the growth response of E. coli to antimicrobials (26) were tested. They consisted of 32 197 
isolates with MIC between 0.24 ug/ml and 2.0 ug/ml (sensitive isolates) and 16 isolates with MIC 198 
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 11
between 16 and 512 ug/ml (resistant isolates). They were grown in LB broth (Oxoid Ltd, Termo-199 
Scientific, Roskilde, Denmark) at 37 ᵒC overnight. Ten-fold dilutions were made in PBS, and 200 
dilutions were plated on McConkey agar without tetracycline and McConkey agar containing 16 201 
ug/ml tetracycline. CFU was counted after 20 hours of incubation at 37 ᵒC and the difference 202 
between CFU estimation on the two plates was determined for each strain.   203 
 204 
Statistics  205 
The clinical trial was set up as a five-treatment-trial, and the statistical analysis for differences 206 
between groups with respect to selection for resistant coliform bacteria was therefore carried out 207 
with all groups in one analysis. The effects of the different treatment protocols on the number of 208 
antimicrobial resistant bacteria were analyzed using either Log10 transformed counts of resistant 209 
bacteria or testing for significant changes in the square root of the proportion or change of 210 
proportion of resistant bacteria, i.e ටோ೅ೣ஼೅ೣ   or ට
ோ೅ೣ
஼೅ೣ /
ோ೅೤
஼೅೤  where R is the CFU/g count on the 211 
antibiotic R plate at time Tx or Ty; and C is the total CFU coliforms at time Tx or Ty. Due to the 212 
uncertainty of CFU counts, proportions could be higher than one; however, proportions above two 213 
were considered outliers and excluded. The square root transformation was selected to improve 214 
the normality of the residuals of the tests. Pigs with drop out data (data missing at any of the time 215 
points T1-T3) were removed from the study, while drop out of data for T4 had to be accepted 216 
because only a small fraction was available for sampling.  217 
 218 
Analyses were performed by Linear Mixed-Effects Models to determine significant differences in 219 
resistant coliform bacteria and fraction of resistant bacteria from T1-T3 using lmer from the 220 
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 12
package lme4 in R version 3.2.2 (27). When testing for the effect of treatment, farm ID and the 221 
interaction between farms and treatment were included as fixed effects, while batch of pigs was 222 
included as a random effect. To identify the significant effects, back wise elimination was 223 
performed using the step function and AIC (Akaike information criterion). Confidence intervals (CI) 224 
were found by bootstrapping using bootMer from the lmerTest package. Test of differences of 225 
multiple groups at single time points was done using Kruskal-Wallis Rank Sum Test (kruskal.test), 226 
while test for differences in numbers or proportions of resistant bacteria between different time 227 
points within group was done using Student’s t-Test (t.test), and correlation was tested using 228 
Pearson's product moment correlation coefficient (cor.test), all in R (27). 229 
 230 
Ethical statement 231 
The clinical trial was approved by the Danish Medicines Agency (License no. 2011090862 / 232 
2012053751), and the participating herd owners signed a written “Owner informed consent” 233 
explaining the scope of the field trial. 234 
 235 
RESULTS 236 
 237 
Effect of treatment-dose and treatment-regimes with OTC on selection of tetracycline resistant 238 
coliform bacteria 239 
In total, 224 pigs received high dose as flock-treatment (HD), 241 pigs received normal dose as 240 
flock-treatment (ND) and 224 pigs received low dose as flock-treatment (LD). 241 pigs belonged to 241 
the pen-wise treatment (PW) group and 221 pigs to the individual intra muscular treatment (IM) 242 
group. In total, samples from 1167 animals were analyzed (Table 1).  243 
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 13
 244 
The method used to count consisted of McConkey agar with added tetracycline. In order to 245 
validate that this method distinguished between terracyline resistant and tetracycline sensistive 246 
coliform bacteria, 49 coliform strains were plated on agar with and without antimicrobials. The 247 
CFUs of cultures of sensitive strains were 7.0 ± 0.5 Log10 units lower on plates containing 248 
tetracycline than on plates without antibiotic, and only one strain showed colonies. The 249 
corresponding values for resistant strains were difference of 0.3 ± 0.5 Log10 units, and all strains 250 
showed colonies (Supplementary material, Figure S1).    251 
 252 
Effect of OTC dose on selection of tetracycline resistant coliform bacteria 253 
As can be seen from figure 1, variation between pigs with respect to Log10 CFU/g tetracycline-254 
resistant coliform was large in all groups at all time-points. The average number of coliform 255 
bacteria and tetracycline resistant coliform bacteria did not differ significantly between groups 256 
before initiation of treatment (T1) (Supplementary material, Figure S2 and Figure 1).  On average, 257 
pigs carried 6.0 ± 0.8 Log10 CFU/g total coliform bacteria and 5.5 ± 0.9 log10 CFU/g tetracycline 258 
resistant coliform bacteria at T1. Treatment irrespective of dose caused a significant rise in the 259 
number of tetracycline-resistant coliforms at T2 followed by a significant drop towards the time 260 
where pigs left the nursery unit (T3) (paired one-sided t-test, p<0.0005). The rise from T1 to T2 was 261 
highest in the HD group. In all three dose-groups, the average Log10 CFU/g tetracycline-resistant 262 
coliform bacteria at slaughter were significantly below the T1 value (paired t-test, one-sided 263 
P<0.05). The proportions of tetracycline-resistant coliforms also increased significantly in all 264 
groups following treatment (paired one-sided t-test, p<0.005), but dropped to below the starting 265 
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point at slaughter (T4) (Figure 2). The differences between proportions at T1 and T4, however, were 266 
not significant.   267 
 268 
We analyzed for the overall effect of treatment-dose on the change in proportion of tetracycline 269 
resistant coliforms between T1 and T3 using a mixed linear model. In this analyses farm was 270 
included as a fixed effect and batch as a random effect. We found no significant effect of 271 
treatment-dose. The only significant effect in the model was the random effect of batch.  272 
 273 
Effect of treatment mode on selection of tetracycline-resistant coliform bacteria  274 
The use of PW or IM treatment strategies, with the aim to treat fewer pigs than by flock-275 
treatment, did not significantly affect the number of tetracycline-resistant coliform bacteria 276 
selected or the proportion of resistant coliforms at different timepoints. As for oral batch-277 
treatment, the number and proportion of resistant bacteria at slaughter (T4) was lower than 278 
before treatment (Figure 1 and Figure 2). The only significant effect in the logistic model here, too, 279 
was the batch effect.  280 
 281 
In both the PW and the IM groups some pigs did not receive treatment (n=26 and n=79) (Table 1). 282 
The mean Log10 CFU/g tetracycline resistant coliforms in these groups at T3 (5.0 Log10 CFU/g and 283 
5.2 Log10CFU/g) were lower than the mean Log10 CFU/g tetracycline resistant coliforms in the 284 
treated pigs (5.4 Log10 CFU/g and 5.3 Log10CFU/g). The difference was significant in the PW group 285 
but not the IM group (two-sided t-test, p=0.01 and p=0.39) (Supplementary material, Figure S2). At 286 
T4, there were no significant differences between treated and untreated pigs in PW group (p=0.06). 287 
 288 
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 15
Control treatment with tiamuline 289 
For animal welfare reasons, the clinical trial did not contain a non-treated, control group. Instead, 290 
a control experiment, where pigs suffering from Lawsonia intracellularis induced diarrhea were 291 
treated with an unrelated antibiotic, tiamuline, was conducted. As shown in Figure 3, treatment 292 
with this drug did not result in a significant increase in the number of tetracycline-resistant 293 
coliforms. Similarly, the proportion of tetracycline-resistant coliform bacteria did not change as a 294 
result of treatment. This showed that the effects seen after OTC treatment were specifically 295 
related to the use of this drug, and did not represent normal development in the coliform flora of 296 
nursery pigs. 297 
 298 
Co-selection for other antibiotics  299 
In all treatment groups, there were no significant differences in number of AMP, SUL and CTX 300 
resistant coliforms before initiation of treatment (data not shown). The counts showed a close, 301 
highly significant correlation between the changes in proportion of tetracycline-resistant coliforms 302 
from T1 to T2 and changes in proportion of ampicillin and sulfonamide resistant coliforms between 303 
the same time points (Pearson's product moment correlation coefficient, P<0.0001), indicating 304 
that these resistances were selected together. On the contrary, no significant correlation was 305 
observed between tetracycline- and cefotaxime-resistant coliforms (data not shown). 306 
Nevertheless, 282 out of the 1167 pigs analyzed were found to carry cefotaxime-resistant 307 
coliforms at T1 (average Log10 CFU in positive pigs was 3.2 with a range from 2.7 (detection limit) to 308 
7.0 Log10 CFU/g), and at least one pig in all farms were positive for cefotaxime-resistant coliforms.  309 
 310 
Discussion 311 
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The purpose of this study was to estimate the effect of OTC treatment dose and treatment 312 
regimes on selection of tetracycline resistant coliforms in nursery pigs under field conditions. We 313 
used an easy agar-dilution counting method, based on including breakpoint concentrations of OTC 314 
to McConkey plates. This method has previously been validated for use with McConkey agar and 315 
added tetracycline (28), however, with 8 ug/ml as the added concentration of tetracyline. We 316 
performed our own method validation with 16 ug/ml tetracycline added to the plates, and found 317 
that this, too, gave 100 % ability to distinguish between tetracycline sensitive and resistant 318 
coliforms. 319 
 320 
In accordance with a previous study (14), we observed a significantly higher number of 321 
tetracycline resistant E. coil right after the treatment in the group receiving the highest dose, but 322 
in contrast to the previous publication, the concentration and proportion returned to the starting 323 
level within 3-4 weeks. Proportions of resistant coliforms at T4, corresponding to shortly before 324 
slaughter and thus the time where the pigs enter the food chain, was significantly below the 325 
before treatment level. Thus, pigs receiving a high dose of tetracycline may shortly show higher 326 
level of resistant bacteria, but according to our results, they do not possess a higher risk of 327 
transfer of resistant bacteria to consumers.  328 
 329 
Reports on proportion of tetracycline resistance in randomly collected E. coli from pigs in Denmark 330 
have been published since the 1970ties (29). Comparison between these old studies and results of 331 
the current surveillance program in Denmark (30) shows that the mean proportion of tetracycline 332 
resistant commensal E. coli has varied over the years, however, it seems never to clime above 333 
approximately 40 %. A possible reason for the minimal selective effect of dose in our study may be 334 
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the very high starting concentrations of resistant bacteria. While this is representative for 335 
proportions of tetracycline resistant commensal E. coli in pigs in Denmark (30), it is much higher 336 
than the 1-10 % chlortetracycline-resistant E. coli detected by Delsol et al (14) prior to their 337 
experiment. Our results may thus not be representative for farms with an initial lower 338 
concentration of tetracycline-resistant bacteria. Compared to previously published studies, a high 339 
number of pigs were included in the present study, and conclusions must be considered strong. 340 
Still, the trails were only conducted in five different herds with quit similar management practices. 341 
We cannot rule out that under very different management practices, results would have been 342 
different. 343 
  344 
Previous studies on the effect of dose on selection of resistance have generally been concerned 345 
with differences between therapeutic and sub-therapeutic concentrations of antibiotics  (see 346 
meta-analysis (31)). In contrast, we considered therapeutic doses. Putting results together, and 347 
including studies from poultry as well, there seems to be minimal effect of treatment dose on 348 
selection of resistant indicator bacteria (31, 32). This indicates that within quit broad ranges, 349 
veterinarians might change dose to achieve a better treatment efficacy, without changing the 350 
selection of resistant bacteria significantly. It should be noted that while 5 mg/kg, corresponding 351 
to the low dose used in the current study, is sufficient to reduce L. intracellularis below the 352 
threshold for pathological changes in the intestine of pigs, it takes 10 mg/kg to eliminate the 353 
bacterium to non-detectable levels (23).   354 
 355 
On a population level, there is a direct association between the intensity of use of antibiotics and 356 
the proportion of bacteria resistant to such antibiotics. This has been demonstrated for clinical as 357 
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well as indicator bacteria and from both humans (33, 34) and farm animals (35), though the 358 
relation is not always straight forward (36). As a consequence, there is a tendency to argue against 359 
flock treatment of farm animals. A large proportion of the reduction in amount of antimicrobials 360 
used in the Netherlands to treat farm animals has been reported to be due to restricted use of 361 
flock treatment (37), and legal restrictions specifying certain pre-conditions on use of flock 362 
medication have been gradually introduced in Denmark. Although phasing out oral flock-363 
treatment leads to less antibiotic usage, it has never been thoroughly investigated whether this 364 
also leads to less resistance under field conditions, where untreated animals are housed in close 365 
proximity to treated animals, and we tried to answer this question in the current study.  366 
 367 
Surprisingly, we did not observe any significant differences in selection of tetracycline resistant 368 
coliform bacteria when we compared oral flock to oral pen-wise (small group) and single animal 369 
IM treatments. This is difficult to explain, given that the overall use of OTC was 15 % and 44 % 370 
lower in the PW and IM treatment groups. A detailed analysis of our results showed that 371 
untreated pigs in the PW group, but not in the IM group, had significantly lower counts of 372 
tetracycline resistant coliforms than the treated pigs in the same groups. The most like 373 
explanation for the lack of difference in in the individual treatment group is that they shared the 374 
environment (the pen) with treated pigs, and thus were exposed to high number of tetracycline 375 
resistant coliforms that were excreted from treated pigs. Contrary to this, untreated pigs in the 376 
PW group always shared the pen with untreated pigs.  377 
 378 
The lack of overall difference between PW and ND groups, we believe, is simply a matter of 379 
numbers. The vast majority of pigs in the PW groups got treated, because the pen fulfilled the 380 
 o
n
 M
ay 17, 2017 by TECH KNO
W
LEDG
E CTR O
F DENM
ARK
http://aem
.asm
.org/
D
ow
nloaded from
 
 19
criterion for treatment against diarrhoea. In that respect, our study confirms previous 381 
observations that once diarrhoea is observed in a fraction of the nursery pigs, there is a high risk 382 
that the remaining pigs are sub-clinically infected (10). Taken together, our results, nevertheless 383 
indicated that a form of treatment, where treated pigs are separated from untreated pigs, might 384 
be a better strategy for reducing antimicrobial resistance than individual treatment, where treated 385 
and untreated pigs share the same pen.  PW and IM treatments with OTC have been shown to be 386 
ineffective compared to flock-treatment for treatment of L. intracellularis diarrhoea (11). When 387 
this observation is combined with our results, continued use of oral flock-treatment seems 388 
justified, at least as far as conditions are similar to those investigated in the current study. In the 389 
study of treatment efficacy (11), the authors argued that oral flock-treatment may be needed as 390 
long as there are no good, rapid and precise diagnostic methods for detection of individual pigs 391 
with intestinal disturbance, since pigs with intestinal disturbance may go unnoticed with current 392 
diagnostic procedures. This puts emphasis on improved diagnostics corresponding well to the 393 
WHO action plan against antimicrobial resistance, which emphasise the need for development of 394 
improved diagnostic tests in the fight against antibiotic resistance (38). The results of the current 395 
study might also indicate that measuring antibiotic consumption is not always a good surrogate for 396 
measuring antimicrobial resistance, even though this is currently one of the cornerstones in 397 
national surveillance programs on antibiotic resistance.  398 
 399 
For animal welfare reasons, we could not leave pigs untreated when outbreaks of diarrhoea was 400 
present. To be able to control for natural development in the coliform flora, we chose instead to 401 
treat a batch with tiamuline, a drug belonging to the groups of pleuromutilins and used exclusively 402 
in veterinary medicine. As this drug does not select for tetracycline resistant coliforms, this group 403 
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could be used to create a baseline for natural fluctuation in numbers and proportions of 404 
tetracycline resistant coliforms in nursery pigs.  The results showed that the fluctuations we 405 
observed in tetracycline treated pigs in the clinical trials were associated with the OCT treatment 406 
and were different from the fluctuations in pigs treated with tiamuline. 407 
 408 
Langlois et al. (39) showed that pigs in herds with a history of previous routine use of antibiotics 409 
developed higher numbers of tetracycline-resistant coliforms following chlortetracycline 410 
treatment than pigs from another herd without such a history. During and before the current 411 
clinical trial, farmers were allowed to treat pigs for other diseases, when needed. Treatments 412 
between birth and T1 may very well influence selection between T1 and T2 by having pre-selected 413 
for tetracycline resistant coliforms. However, we systematically collected data on consumption of 414 
antibiotics in the period from T1 to T3 and analysed for the effect of pre- and post-treatment with 415 
other antibiotics on selection for tetracycline resistant coliforms. The results showed no significant 416 
effect of the three most commonly additional treatments and we ruled out additional treatments 417 
as a confounding factor. After time point T3, pigs were distributed to different fattening units, and 418 
only a fraction of pigs were re-sampled at T4. No records on antibiotic use were available to us 419 
covering the time periods from birth to T1 and between T3 and T4. We cannot rule out that 420 
treatment between T3 and T4 may be the reason for lack of differences between groups at T4. 421 
However, in general, number of treatments in the fattening period are far below the number in 422 
the nursery period in Danish pig production (8), making this less critical for the current study.  423 
 424 
The fact that flock and pen-wise (small group) treatment was carried out as water medication 425 
introduced an uncertainty with regard to dose obtained by the individual pig. We ensured that the 426 
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dose given to the flock and the pen was consumed (in total), but we could not ensure that all pigs 427 
received equal treatment. This means that dose in flock treated and pen-wise treated groups is an 428 
average of pigs, and there will be variation between pigs. Similarly, treatments (T1) were initiated 429 
when the clinical inclusion criterion was fulfilled, while T3 (end of the nursery period) was a fixed 430 
date for each pig. This introduced variation in the duration of the period between T1 and T3, and 431 
this too may be a factor in lack of significant differences between treatments. On the other hand, 432 
this is the situation in real life, and our results represent the naturally occurring variation in dosing 433 
and treatment time under field conditions.  434 
 435 
Besides being tetracycline resistant, commensal E. coli from food animals in Denmark are 436 
commonly resistant to ampicillin and sulphonamides (8), indicating co-selection, and a study from 437 
the United States indicated that tetracycline treatment of calves could lead to co-selection for 438 
resistance genes encoding 3rd and 4th generation cephalosporin resistance (40). It has been 439 
reported that commensal tetracycline-resistant E. coli are often resistant to ampicillin and further 440 
they may carry class-1 integrons encoding sulfonamide resistance genes (41). To test whether 441 
tetracycline treatment resulted in specific increase of coliforms with other resistance markers, all 442 
samples were also cultured on MacConkey agar containing ampicillin, sulfonamide or cefotaxime.  443 
The latter drug was included to investigate possible selection of extended-spectrum beta-444 
lactamase (ESBL)-producing bacteria, which constitute a growing health concern (42).  445 
In the current study, selection of tetracycline-resistant coliforms from T1 to T2 was significantly 446 
associated with selection for ampicillin- and sulphonamide-resistant coliforms. Since we have not 447 
characterized the bacteria counted in the current study, we cannot prove that this is co-selection 448 
caused by co-localization of the resistance genes, but the observation is hard to explain by any 449 
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other mechanisms. One of the most prominent antibiotic resistance threats to human health is the 450 
growing prevalence of ESBL producing Gram-negative bacteria (43). In the current study we found 451 
that ESBL producing coliforms could be identified in all farm and on average approximately 20 % of 452 
the pigs were shown to be carriers. However, there is currently no indication that pigs are and 453 
important reservoir for ESBL infection in humans in Denmark (8), and based on our results, the use 454 
of tetracycline can be ruled out as a (co)selection factor for such bacteria. The Danish pig industry 455 
does not use cephalosporin drugs, and due to this the prevalence of ESBL has decreased rapidly in 456 
recent years (35). 457 
 458 
Several studies have been published recently, modelling development of tetracycline resistance in 459 
pigs following different treatment scenarios (22, 44-46). Such models have been fed with data on 460 
growth responses in E. coli to different concentrations of tetracycline. In relation to our study, the 461 
multi-strain, multi-pig model by Græsbøll et al. (22) is the most relevant. This model predicts, that 462 
high dose will results in a higher proportion of tetracycline resistant bacteria than low dose. In that 463 
sense our field study is in agreement with the results of the model. However, the modelling also 464 
predicts that the proportion will return to pre-treatment level in a dose dependent manner. This 465 
prediction was not confirmed by our field study. At T3 there was no significant difference between 466 
treatment groups. 467 
 468 
Measuring resistance in coliform bacteria is a widely used method for studies of development of 469 
antibiotic resistance in bacterial populations, both in the society in general and in intervention 470 
studies (47), but it is a narrow approach. It is therefore indicated to make follow up studies where 471 
one looks at the changes in the microbiome in general, since not only coliform bacteria will be a 472 
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risk for transfer of resistance genes to human pathogenic bacteria through the food chain. Such 473 
studies should preferably be carried out using culture independent techniques.  474 
 475 
In conclusion, the current study showed that dose of oxytetracycline during flock treatment and 476 
mode of application did not have a significant influence on the selection of coliform bacteria in the 477 
intestine of nursery pigs, under the conditions tested. This means that doses can be set putting 478 
emphasis on consideration to efficacy and prize of treatment, and that, from an antibiotic 479 
resistance point of view, there appears to be no benefits from using single animal treatment, 480 
unless treated animals are separated from non-treated pen-mates.      481 
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Table 1. Overview of number of pigs included in the study in each treatment group, as distributed on the 619 
five participating farms 620 
 
 
Treatment 
Oral batch-
treatment 
high dose 
HD 
Oral batch-
treatment 
normal 
dose 
ND 
Oral batch-
treatment 
low dose 
LD 
Oral pen-
wise 
treatment 
PW 
Treated 
pigs  
Oral pen-
wise 
treatment, 
untreated 
pigs 
Individual 
injection 
treatment  
IM 
treated 
pigs 
Individual 
injection 
treatment 
untreated 
pigs 
Farm T1-
T3a 
T4b T1-T3 T4 T1-T3 T4 T1-T3 T4 T1-T3 T4 T1-T3 T4 T1-T3 T4
A 45 19 46 17 45 20 40 20 21 6 24 10 21 6 
B 60 33 30 23 45 29 37 23 8 5 26 11 19 17 
C 44 18 59 30 44 12 43 20 1 1 22 11 18 11 
D 45 5 45 13 45 0 46 6 0 0 24 1 21 1 
E 46 0 61 1 45 0 38 0 7 0 28 0 18 0 
Total 240 75 241 84 224 61 204 69 37 12 124 33 97  35 
T1 – T4 refer to the time points where samples were obtained. T1 was immediately before treatment, T2 621 
was to days after end of treatment, T3 corresponded to the time where pigs left the nursery unit, and T4 622 
was 1-4 days before slaughter.  623 
  624 
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Legend to figures. 625 
 626 
Figure 1. Box plot illustrating Log10 CFU/g tetracycline resistant coliforms in fecal samples from pigs 627 
at different time points relative to treatment with different doses of OTC or given OTC by different 628 
modes of treatment. Normal, Low and High refer to groups of pigs subjected to five days of oral 629 
OTC batch treatment using 10 mg/kg (ND), 5 mg/kg (LD), and 20 mg/kg (HD) dosages, respectively.  630 
Injection (IM) and Pen (PW) refer to groups treated with 10 mg/kg OTC for five days individually by 631 
injection and pen-wise. T1-T4 refers to the time points where fecal samples were obtained: T1: 632 
immediately before treatment, T2: two days after end of treatment, T3: when pigs left the nursery 633 
unit, T4: 1-7 days before slaughter. The boxes indicate the interquartile range. The open circles 634 
indicate data points more than 1.5 times the interquartile range from the median. 635 
  636 
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Figure 2. Box plot illustrating the square root of proportions of tetracycline resistant coliforms in 637 
fecal samples from pigs at different time points relative to treatment with different doses of OTC 638 
or with different treatment modes. Normal (ND), Low ((LD) and High (HD) refer to groups of pigs 639 
subjected to five days of oral OTC batch treatment using 10 mg/kg, 5 mg/kg, and 20 mg/kg 640 
dosages, respectively.  Injection (IM) and Pen (PW) refer to groups treated with 10 mg/kg OTC for 641 
five days individually by injection and pen-wise treatment, respectively. T1-T4 refers to the time 642 
points where fecal samples were obtained: T1: immediately before treatment, T2: two days after 643 
end of treatment, T3: when pigs left the nursery unit, T4: 1-7 days before slaughter. The boxes 644 
indicate the interquartile range. The open circles indicate data points more than 1.5 times the 645 
interquartile range from the median. 646 
  647 
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Figure 3. Log10CFU/g tetracycline-resistant coliforms (A) and proportion of tetracycline resistant 648 
coliforms (B) in fecal samples from pigs treated orally as batch-treatment with tiamuline for three 649 
days. T1-T3 refers to the time points where fecal samples were obtained: T1: Immediately before 650 
treatment, T2: Two days after end of treatment, T3: When pigs left the nursery unit. The boxes 651 
indicate the interquartile range. The open circles indicate data points more than 1.5 times the 652 
interquartile range from the median. 653 
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